Evidence map›Paper›PMID 21853109›Full record

ArticlePloS one2011

Frequent alteration of MLL3 frameshift mutations in microsatellite deficient colorectal cancer.

Yoshiyuki Watanabe, Ryan J Castoro, Hyun Soo Kim, Brittany North, Ritsuko Oikawa, Tetsuya Hiraishi, Saira S Ahmed, Woonbok Chung, Mee-Yon Cho, Minoru Toyota and 5 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 71 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Pancreatic intraductal tubulopapillary neoplasm is genetically distinct from intraductal papillary mucinous neoplasm and ductal adenocarcinoma.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2017
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 3 countries.

Yoshiyuki WatanabeDepartment of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America. ponponta@marianna-u.ac.jp
Ryan J Castoro
Hyun Soo Kim
Brittany North
Ritsuko Oikawa
Tetsuya Hiraishi
Saira S Ahmed
Woonbok Chung
Mee-Yon Cho
Minoru Toyota
Fumio Itoh
Marcos R H Estecio
Lanlan Shen
Jaroslav Jelinek
Jean-Pierre J Issa
The University of Texas MD Anderson Cancer Center · USSt. Marianna University School of Medicine · JPSapporo Medical University · JPYonsei University · KR

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
DNA Methylation in Colon Cancer MetastasisR01CA098006 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI ISSA, JEAN-PIERRE J. · 2004 to 2008
$1.4M
Diet and DNA methylation in colon mucosa and adenomasR01CA105346 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI ISSA, JEAN-PIERRE J · 2004 to 2007
$1.1M
NCI NIH HHS CA098006NCI NIH HHS CA105346NCI NIH HHS CA16672NCI NIH HHS P30 CA016672NCI NIH HHS R01 CA098006NCI NIH HHS R01 CA105346
6 · The paper itself

Abstract

backgroundMLL3 is a histone 3-lysine 4 methyltransferase with tumor-suppressor properties that belongs to a family of chromatin regulator genes potentially altered in neoplasia. Mutations in MLL3 were found in a whole genome analysis of colorectal cancer but have not been confirmed by a separate study. METHODS AND

resultsWe analyzed mutations of coding region and promoter methylation in MLL3 using 126 cases of colorectal cancer. We found two isoforms of MLL3 and DNA sequencing revealed frameshift and other mutations affecting both isoforms of MLL3 in colorectal cancer cells and 19 of 134 (14%) primary colorectal samples analyzed. Moreover, frameshift mutations were more common in cases with microsatellite instability (31%) both in CRC cell lines and primary tumors. The largest isoform of MLL3 is transcribed from a CpG island-associated promoter that has highly homology with a pseudo-gene on chromosome 22 (psiTPTE22). Using an assay which measured both loci simultaneously we found prominent age related methylation in normal colon (from 21% in individuals less than 25 years old to 56% in individuals older than 70, R = 0.88, p<0.001) and frequent hypermethylation (83%) in both CRC cell lines and primary tumors. We next studied the two loci separately and found that age and cancer related methylation was solely a property of the pseudogene CpG island and that the MLL3 loci was unmethylated.

conclusionsWe found that frameshift mutations of MLL3 in both CRC cells and primary tumor that were more common in cases with microsatellite instability. Moreover, we have shown CpG island-associated promoter of MLL3 gene has no DNA methylation in CRC cells but also primary tumor and normal colon, and this region has a highly homologous of pseudo gene (psiTPTE22) that was age relate DNA methylation.

Indexed as

Base SequenceCell Line, TumorColorectal NeoplasmsDNA-Binding ProteinsDNA MethylationDNA Mutational AnalysisFemaleFrameshift MutationGene Expression Regulation, NeoplasticGenome, HumanHumansMaleMicrosatellite RepeatsMiddle AgedMolecular Sequence DataReproducibility of ResultsDNA-Binding ProteinsKMT2C protein, human

Identifiers

PMID21853109
PMCPMC3154922
OpenAlexW2022985713

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.